Indian Journal of Medical Microbiology Home 

BRIEF COMMUNICATION
[Download PDF]
Year : 2008  |  Volume : 26  |  Issue : 4  |  Page : 369--371

Status of high level aminoglycoside resistant Enterococcus faecium and Enterococcus faecalis in a rural hospital of central India

DK Mendiratta, H Kaur, V Deotale, DC Thamke, R Narang, P Narang 
 Department of Microbiology, Mahatma Gandhi Institute of Medical Sciences, Sevagram- 442 102, Maharashtra, India

Correspondence Address:
D K Mendiratta
Department of Microbiology, Mahatma Gandhi Institute of Medical Sciences, Sevagram- 442 102, Maharashtra
India

Abstract

Considering the emergence of high level aminoglycoside resistance (HLAR) in enterococci this study was undertaken to determine their status in a rural setting. HLAR by disc diffusion and agar dilution, β lactamase by nitrocefin disc and vancomycin resistance by agar dilution was determined in 150 enterococcal isolates, as per NCCLS guidelines. Only two species, Enterococcus faecalis (85.5%) and Enterococcus faecium (14.7%) were recovered, mostly from blood. Forty six percent showed HLAR. Multi drug resistance and concomitant resistance of HLAR strains to β lactams were quite high. None showed β lactamase activity or vancomycin resistance.

How to cite this article:
Mendiratta D K, Kaur H, Deotale V, Thamke D C, Narang R, Narang P. Status of high level aminoglycoside resistant Enterococcus faecium and Enterococcus faecalis in a rural hospital of central India.Indian J Med Microbiol 2008;26:369-371

How to cite this URL:
Mendiratta D K, Kaur H, Deotale V, Thamke D C, Narang R, Narang P. Status of high level aminoglycoside resistant Enterococcus faecium and Enterococcus faecalis in a rural hospital of central India. Indian J Med Microbiol [serial online] 2008 [cited 2020 Feb 26 ];26:369-371
Available from: http://www.ijmm.org/text.asp?2008/26/4/369/43582

Full Text

Regarded as nosocomial pathogen of the 1990s, enterococci have become increasingly important not only because of their ability to cause serious infections but also because of their increasing resistance to many antimicrobial agents. Serious enterococcal infections are often refractory to treatment and the mortality is high. [1] Infections by enterococci have traditionally been treated with cell wall active agents (e.g., penicillin or ampicillin) in combination with an aminoglycoside (streptomycin / gentamicin), however emergence of high level resistance to aminoglycosides (HLAR), β lactam antibiotics and to vancomycin by some strains, together with association of HLAR with multi drug resistance has led to failure of synergistic effects of combination therapy.[1],[2],[3] Streptomycin was the aminoglycoside used clinically until 1970 when more than 50% of enterococci were found to be resistant to high level of this drug. [1] High level gentamicin resistance (HLGR) was first reported in E.faecalis 1979. [1]

The present study was undertaken considering the paucity of data on high level aminoglycoside resistance (HLAR) in enterococci, especially from a rural set-up and due to the fact that enterococci are the second leading cause of hospital acquired infection and the third leading cause of bacteraemia. [4]

 Materials and Methods



Enterococci recovered from various specimens between June 2003 and January 2004 were identified and speciated by test scheme proposed by Facklam and Collins. [5] Our hospital primarily caters to the rural population of Central India.

Antibiotic susceptibility testing was done by Kirby Bauer disc diffusion method using discs and Mueller Hinton Agar (Himedia) as recommended by NCCLS. [6] High content gentamicin and streptomycin discs were prepared locally, [7] using pure powders obtained from Ranbaxy and Hindustan antibiotics respectively. Minimum inhibitory concentration (MIC) of streptomycin / gentamicin by agar dilution, β lactamase activity by nitrocefin disc and screening for vancomycin resistance by agar dilution was done as recommended by NCCLS. [6] Staphylococcus aureus ATCC 25923 and E. faecalis ATCC 29212 were used to check quality of routine and high content discs respectively.

 Results



Of the 150 (1.16%) enterococcal isolates recovered from 12890 specimens, 128 (85.3%) were identified as E. faecalis and 22 (14.7%) as E. faecium which were isolated primarily from blood (77.3% and 24.2% respectively) and isolation of E. faecium was significantly higher (p E. faecalis . E. faecium was not isolated from urine as against the recovery of 13.3% of E. faecalis from urine.

A total of 69 (46%) isolates showed high level resistance to gentamicin and/or streptomycin by both, high content disc diffusion and agar dilution (MIC). HLAR among E. faecium isolates (95.5%) was significantly higher than E. faecalis (37.5%) (c1-c2 p E. faecium (59.1%) as compared to E. faecalis (7.8%) (d1-d2, [Table 1]). There was no difference in resistance of E. faecalis to either gentamicin or streptomycin (14.8% each alone and 22.6% each overall - a1-a2 [Table 1]), however, in E. faecium it was higher to gentamicin (22.7% alone and 81.8% overall) than to streptomycin (13.6 alone 72.7% overall). None of these differences were however, statistically significant. None of the 150 enterococcal isolates showed β-lactamase activity or vancomycin resistance.

Both E. faecalis and E. faecium showed multi drug resistance, the former to as many as nine and latter to as many as eight drugs. It was observed that resistance of HLGR / HLSR isolates to various antibiotics (except to rifampicin and by HLSR to chloramphenicol) was more in E. faecium than E.faecalis , however this difference in the two species was statistically not significant [Table 2].

Concomitant resistance of HLGR and HLSR strains to β lactam antibiotics was quite high in both the species. In case of HLGR, overall it was 91.4% with penicillin and 87.2% with ampicillin, while in case of HLSR it was 93.3% and 88.8% respectively [Table 2].

 Discussion



Recent years have witnessed increased interest in enterococci not only because of their ability to cause serious infections but also because of their increasing resistance to many antimicrobial agents. [1],[2],[3] In the present study only two species E. faecalis (85.3%) and E. faecium 22 (14.7%) were recovered in contrast to additionally more by others from India. [8],[9] Our isolation rate was close to that from Nagpur [10] ( E. faecalis 86% and E. faecium 14%) 80 km away and Coimbatore [11] (88% E. faecalis ). However, report of higher isolation of E. faecium (80.7%) over E. faecalis (19.2%) has been there from Mumbai. [12]

Antibiotic resistance in enterococci is either intrinsic or acquired. Intrinsic traits expressed by enterococci include resistance to semisynthetic penicillinase resistant penicillins, cephalosporins, low level of aminoglycosides and low level of clindamycin, whereas acquired resistance includes resistance to chloramphenicol, erythromycin, high level of clindamycin, tetracycline, high level of aminoglycosides, penicillin, fluroquinolones and vancomycin. [1] HLAR is due to release of various amnoglycoside modifying enzymes.

In the present study, 46% of the enterococci showed HLAR and combined HLGR and HLSR was significantly (p E. faecium (59.1%) than E. faecalis (7.8%), as also reported by Gordon et al . [13] High HLGR in E. faecalis and HLSR in E. faecium observed has also been reported [8],10] as also vive a versa [13] and no such difference. [12]

We, in this rural set up, found the prevalence of HLSR E. faecalis and E. faecium and HLGR E. faecalis to be lower while that of HLGR E. faecium to be slightly higher than that reported from urban hospitals. [8],[10],[12],[15] The reason for higher prevalence in urban hospitals could be because of the set up where chronic cases are prevalent and there is wider usage of broad spectrum antibiotics.

Resistance to aminoglycosides in enterococci is often associated with multidrug resistance. [1] In our study, E. faecalis showed resistance to as many as nine and E. faecium to as many as eight drugs. Concomitant resistance of HLGR and HLSR strains to the two β lactam antibiotics (penicillin and ampicillin) was quite high in both the species and it was higher to penicillin than ampicilln in E. faecalis [Table 2]. Concomitant HLAR, high level penicillin resistance and resistance to vancomycin has been reported in 16% isolates by Aggarwal et al [10] from Nagpur. Resistance to penicillin and ampicillin, which is usually intrinsic, is primarily due to low affinity of the penicillin binding proteins [3] and it results in loss of synergistic effect between β lactams and aminoglycosides leading to treatment failures.

HLGR has also been linked to β lactamase production, resistance to ciprofloxacin[14] and chloramphenicol. [1],[14] In fact Schouten et al [14] reported that as the prevalence of HLGR increases, β lactamase production in Enterococci may also increase. Though none of our isolates were β lactamase producers, as also reported by Jessudason et al ., [2] both E. faecium and E. faecalis showed concomitant resistance to ciprofloxacin and chloramphenicol [Table 2]. Addition of resistance due to β lactamase production to the intrinsic resistance already seen in enterococci is of major concern.

Rifampicin is useful against multidrug resistant enterococci and often given in combination as alone has poor bactericidal activity. [15] Resistance to rifampicin was observed in both HLAR positive and negative isolates in our study, it being higher in latter, though not statistically significant.

The problem of VRE may not be very high in India [8],[10],[12] as also seen in our rural hospital at present but monitoring of VRE is the need of hour since it appears to be an emerging pathogen in India. This study revealed the prevalence of multidrug resistant HLAR strains of E. faecalis and E. faecium in this rural hospital.

References

1Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev 1990;3:46-65.
2Jesudason MV, Pratima VL, Pandian R, Abigail S. Characterization of penicillin resistant Enterococci. Indian J Med Microbiol 1998;16:8-16.
3Patterson JE, Zervos M. High-level gentamicin resistance in Enterococcus: Microbiology, genetic basis and epidemiology. Rev Infect Dis 1990;12:644-51.
4Moellering RC Jr. Emergence of Enterococcus as a significant pathogen Clin Infec Dis 1992;14:1173-8.
5Facklam RR, Collins MD. Identification of Enterococcus species isolated from human infections by conventional test scheme J Clin Microbiol 1989;24:731-4.
6NCCLS. Performance Standards for antimicrobial susceptibility testing; Twelfth Informational Suppliment. NCCLS document M100-S12[ ISBN 1-56238-454-6]. NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2002.
7Sahm DF, Torres C. High content aminoglycoside disks for determining aminoglycoside-penicillin synergy against Enterococcus faecalis . J Clin Microbiol 1988;26:257-60.
8Bhat KG, Chitra P, Bhat M. High level aminoglycoside resistance in Enterococci isolated from hospitalized patients. Indian J Med Res 1997;105:198-9.
9Desai PJ, Pandit D, Mathur M, Gogete A. Prevalence, identification and distribution of various species of enterococci isolated from clinical specimens with special reference to UTI in catheterized patients. Indian J Med Microbiol 2001;19:132-7.
10Agarwal VA, Jain YI, Pathak AA. Concomitant high level resistance to penicillin and aminoglycosides in enterococci at Nagpur, Central India. Indian J Med Microbiol 1999;17:85-7.
11Parvathi S, Appala Raju B. Comparative evaluation of β lactamase production in enterococci by acidometric method and clover leaf technique. Indian J Med Microbiol 2000;18:122-24.
12Karmarkar MG, Gersham ES, Mehta PR. Enterococcal infections with special reference to phenotypic characterization and drug resistance. Indian J Med Res 2004;119:22-5.
13Gordon S, Swenson J, Hill BC, Pigott NE, Facklam RR, Cooksey RC, et al . Antimicrobial susceptibility patterns of common and unusual species of Enteroccoci causing infections in United States. J Clin Microbiol 1992;30:2373-8.
14Schouten MA, Voss A, Hoogkamp-Korstanje; the Europeon VRE study group. Antiicrobial susceptibility patterns of Enterococci causing infections in Europe. Antimicrob Agents Chemother 1999;43:2542-6.
15Cetinkaya Y, Falk P, Mayhah CG. Vancomycin resistant Enterococcus. Clin Microbiol Rev 2000;13:686-707.